Biopharmas raising money in public or private financings, including: Bioversys, Cocrystal, Iterum, Kintara, Lumen, Luca, Painreform, Selecta, Zosano.

New hires and promotions in the biopharma industry, including: Acepodia, Adamas, Blueprint Medicines, Cytodyn, Egenesis, Liminal, Oculis, NPC, Sumitomo Dainippon, Ultragenyx, Zentalis.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Arrakis, Bharat, Biocryst, Cheplapharm, Elektrofi, Glycomimetics, Immutep, Kalos, Leo, Ligand, Lineage, Maat, Metagenomi, Mindset, Novavax, PDL, Qualigen, Resverlogix, Regulus, Sanofi, Seneca, Sotio, Unum, Vallaurix, Vor.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dialco, Masimo.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Coghlin Companies, Cogmedix, Concord Medical, Dominion Aesthetics, Formsense, Genesis Medtech, Nowdiagnostics, Ontrak, Todos Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Onduo.

Med-tech firms raising money in public or private financings, including: Aereus Technologies, Vessi Medical.

New hires and promotions in the med-tech industry, including: Mannkind.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acasti, Akari, Axsome, Bluebird, Eiger, Embera, GSK, Imbrium, Kiadis, Maat, Mirum, NGM, Novan, Novartis, Orpheris, Provention, Regenerx, Shattuck, VBI, Vir.

Biopharmas raising money in public or private financings, including: Biodol, Cohbar, Compass, Pyramid, Tracon.